Institutional-grade intelligence for professional investors

LIVE

•Real-time feeds•Global markets•24/7 coverage

Revenue Net Income P/E P/S EBIT Dividend Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE

West Pharmaceutical Services Liabilities 2025

West Pharmaceutical Services Liabilities

961.1 M USD

Ticker

WST

ISIN

US9553061055

WKN

864330

Revenue Net Income P/E P/S EBIT Dividend Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE

In 2025, West Pharmaceutical Services's total liabilities amounted to 961.1 M USD, a 1.33% difference from the 948.5 M USD total liabilities in the previous year.

West Pharmaceutical Services Aktienanalyse

What does West Pharmaceutical Services do?

West Pharmaceutical Services Inc. is a leading company in the development and manufacturing of innovative solutions for drug delivery and medical devices. The company has been in the market for over 100 years and is headquartered in Exton, Pennsylvania, USA. West operates in more than 50 countries worldwide and employs over 9,000 employees. The history of West Pharmaceutical Services begins in 1923, when Herman O. West founded the company in Philadelphia. Initially, West primarily produced rubber seals for canning jars and bottle closures. In the 1930s, West entered the production of plastic parts used in products such as tube radios. In the mid-1950s, West began to venture into the production of medical devices and accessories, such as syringe stoppers. Since then, the company has continuously expanded its product range and is now a leading provider of pharmaceutical delivery solutions. West is divided into three business segments: Healthcare Delivery Systems (HDS), Pharmaceutical Packaging Systems (PPS), and Contract Manufacturing Organization (CMO). The Healthcare Delivery Systems (HDS) segment specializes in the development and manufacturing of devices and systems for drug delivery. This includes syringes, injection devices, pen systems, nasal and inhalation devices. These products are developed in collaboration with various pharmaceutical companies to simplify and improve medication delivery. West has also developed many patented products, such as the "SmartDose" system, which enables accurate dosage delivery. The Pharmaceutical Packaging Systems (PPS) segment offers packaging solutions for pharmaceuticals. This includes injection vials, caps, and closures made of glass or plastic. PPS has also developed specialized packaging solutions, such as the "Ready Pack" solution, which packages sterile products in a safe and user-friendly environment. Another example is the "Westar UD" system, which allows for accurate and safe dosing of medications in ampoules. The Contract Manufacturing Organization (CMO) segment offers customized services, including design and development of packaging solutions and manufacturing of pharmaceuticals and medical devices. CMO manufacturing services include development, manufacturing, filling, and packaging of sterility products. West has a wide customer base in the pharmaceutical and biotech industry. The company works closely with its customers to develop customized solutions that meet their specific needs. West also has strong partnerships with other leading companies in the industry, such as Merck or Daikyo. Overall, West Pharmaceutical Services is distinguished by its high focus on quality and safety. The company places great emphasis on compliance with regulatory requirements and the use of safety-conscious manufacturing technologies. West also has its own quality control department, which ensures the high quality of its products and satisfies its customers. In summary, West Pharmaceutical Services is a leading provider of pharmaceutical delivery solutions and packaging solutions. With a wide portfolio of innovative products and services tailored to meet customer needs, West can provide safe and effective solutions to its customers worldwide. West Pharmaceutical Services ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing West Pharmaceutical Services's Liabilities

West Pharmaceutical Services's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating West Pharmaceutical Services's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing West Pharmaceutical Services's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

West Pharmaceutical Services's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in West Pharmaceutical Services’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about West Pharmaceutical Services stock

What is the level of liabilities of West Pharmaceutical Services this year?

West Pharmaceutical Services has a debt balance of 961.1 M USD this year.

What were the liabilities of West Pharmaceutical Services compared to the previous year?

The liabilities of West Pharmaceutical Services have increased by 1.33% increased compared to the previous year.

What are the consequences of high debt for investors of West Pharmaceutical Services?

High liabilities can pose a risk for investors of West Pharmaceutical Services, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in West Pharmaceutical Services?

Low liabilities mean that West Pharmaceutical Services has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of West Pharmaceutical Services affect the company?

An increase in liabilities of West Pharmaceutical Services can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of West Pharmaceutical Services affect the company?

A decrease in the liabilities of West Pharmaceutical Services can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of West Pharmaceutical Services?

Some factors that can influence the liabilities of West Pharmaceutical Services include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of West Pharmaceutical Services so important for investors?

The liabilities of West Pharmaceutical Services are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can West Pharmaceutical Services take to modify the liabilities?

To change its liabilities, West Pharmaceutical Services can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does West Pharmaceutical Services pay?

Over the past 12 months, West Pharmaceutical Services paid a dividend of 0.61 USD . This corresponds to a dividend yield of about 0.25 %. For the coming 12 months, West Pharmaceutical Services is expected to pay a dividend of 0.71 USD.

What is the dividend yield of West Pharmaceutical Services?

The current dividend yield of West Pharmaceutical Services is 0.25 %.

When does West Pharmaceutical Services pay dividends?

West Pharmaceutical Services pays a quarterly dividend. This is distributed in the months of March, May, August, December.

How secure is the dividend of West Pharmaceutical Services?

West Pharmaceutical Services paid dividends every year for the past 54 years.

What is the dividend of West Pharmaceutical Services?

For the upcoming 12 months, dividends amounting to 0.71 USD are expected. This corresponds to a dividend yield of 0.29 %.

In which sector is West Pharmaceutical Services located?

West Pharmaceutical Services is assigned to the 'Health' sector.

Wann musste ich die Aktien von West Pharmaceutical Services kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of West Pharmaceutical Services from 11/19/2025 amounting to 0.22 USD, you needed to have the stock in your portfolio before the ex-date on 11/12/2025.

When did West Pharmaceutical Services pay the last dividend?

The last dividend was paid out on 11/19/2025.

What was the dividend of West Pharmaceutical Services in the year 2024?

In the year 2024, West Pharmaceutical Services distributed 0.78 USD as dividends.

In which currency does West Pharmaceutical Services pay out the dividend?

The dividends of West Pharmaceutical Services are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The West Pharmaceutical Services stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von West Pharmaceutical Services

Our stock analysis for West Pharmaceutical Services Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of West Pharmaceutical Services Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.